期刊文献+

AA、MDS和AML患者CD4^+T细胞亚群的变化及其临床意义 被引量:14

Changes and clinical significances of CD4^+T cell subsets in aplastic anemia, myelodysplastic syndromes and acute myeloid leukemia patients
原文传递
导出
摘要 目的探讨CD4+T细胞亚群(Th1、Th2、Th17及Treg细胞)在再生障碍性贫血(AA)、骨髓增生异常综合征(MDS)、急性髓系白血病(AML)患者免疫发病机制中的作用,为临床治疗提供实验依据。方法采用流式细胞术检测AA组25例,MDS组48例[其中难治性贫血(MDS-RA)22例,难治性贫血伴原始细胞增多(MDS-RAEB)26例],AML组12例和正常对照组8例的外周血单个核细胞Th1、Th2、Th17及Treg细胞比例并对比分析,评价各组的细胞免疫状态。结果与正常对照组相比,AA组Th1、Th17细胞及Th1/Th2升高,而Th2和Treg细胞比例减低(P<0.05);MDS组Th1、Th2细胞、Th1/Th2与正常对照组比较差异均无统计学意义(P>0.05),而Th17和Treg细胞比例升高(P<0.05);MDS-RA组Th1、Th17细胞比例和Th1/Th2均升高(P<0.05),Th2细胞比例减低(P<0.05),而Treg细胞比例差异无统计学意义(P>0.05);MDS-RAEB组和AML组Th1、Th17细胞比例和Th1/Th2减低(P<0.05),Th2和Treg细胞比例升高(P<0.05)。结论 AA、MDS不同阶段与AML患者的细胞免疫状态不同,在AA和MDS早期阶段,免疫因素介导的凋亡过度是骨髓衰竭的主要原因;而在MDS晚期和AML阶段,异常克隆细胞的大量积聚可能是其主要原因。 Objective To investigate the role of CD4+T cell subsets in the immune pathogenesis of aplastic anemia(AA),myelodysplastic syndromes(MDS),and acute myeloid leukemia(AML).Methods Flow cytometry was used to detect the proportion of T helper and Treg cells in peripheral blood mononuclear cells of 48 MDS,25 AA,12 AML patients and 8 normal controls.Results Compared with the control group,the percentages of Th1 and Th17 cells and Th1/Th2 were higher,but the percentages of Th2 and Treg cells were lower in the AA group(P0.05).There was no significant difference in the percentages of Th1,Th2,Treg cells and Th1/Th2 between the MDS group and the control group(P0.05),but the percentages of Th17 and Treg cells were higher in the MDS group(P0.05).The percentages of Th1,Th17 cells and Th1/Th2 were higher and the percentage of Th2 cells was lower in the MDS-RA group,but there was no difference in the percentage of Treg cells between the MDS-RA group and the control group(P0.05).In the AML and MDS-RAEB groups,the percentages of Th1 and Th17 cells and Th1/Th2 were significantly lower and the percentages of Th2 and Treg cells were higher than the normal controls(P0.05).Conclusions Immune status is different in AA,variant MDS stages and AML.Immune-mediated excessive apoptosis could induce bone marrow failure in AA and the early stage of MDS.The large accumulation of abnormal clones could induce bone marrow failure in AML and late stage of MDS.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第3期66-70,共5页 Journal of Shandong University:Health Sciences
关键词 骨髓增生异常综合征 再生障碍性贫血 急性髓系白血病 TH细胞 TREG细胞 流式细胞术 Myelodysplastic syndromes Aplastic anemia Acute myeloid leukemia T helper cells Treg cells Flow cytometry
  • 相关文献

参考文献15

  • 1Young N S, Scheinberg P, Calado R T. Aplastic anemia [J].Curr Opin Hematlol, 2008, 15(3) :162-168.
  • 2Sloand E M, Rezvani K. The role of the immune system in myelodysplasia implications for therapy [ J ] . Sem in Hematol, 2008, 45 (1):39-48.
  • 3张之南.血液病诊断与疗效标准[M].3版.北京:科学技术出版社,2007:232-235.
  • 4Mosmann T R, Cherninski H, Bond M W, et al. Two types of murine helper T cell clone. I. Definition accord- ing to profiles of lymphokine activities and secreted pro- teins[J]. J Immunl, 1986, 136(7) :2348-2357.
  • 5Stockinger B, Ve ldhoen M. Differentiation and function of Thl7 T cells [J]. Curr Opin Immunol, 2007, 19(3) : 2R 1 -~R6.
  • 6Shahram Y, Kordasti, Behdad Afzail, et al. IL-17-produ- cing CD4 ( + ) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syn- drome[J]. Br J Haematol, 2009, 145 ( 1 ) :64-72.
  • 7Solomou E E, Rezvani K, Mielke S, et al. Deficient CD4+CD25 + FOXP3 + T regulatory cells in acquired aplastic anemia[J].Blood, 2007, 110(5) : 1603-1606.
  • 8何广胜,邵宗鸿,吴德沛,王秀丽,苗瞄,刘鸿,施均,白洁,孙娟,贾海蓉,钱林生,杨崇礼.重型再生障碍性贫血和骨髓增生异常综合征骨髓中T辅助细胞亚群的变化[J].现代免疫学,2004,24(5):417-419. 被引量:10
  • 9Regis Peffault de Latour, Valeria Visconte, Tomoiku Takaku, et al. Thl7 immune responses contribute to the pathophysiology of aplastic anemia [J].Blood, 2010, 116(20) :4175-4184.
  • 10杨隽,王椿,谢匡成,颜式可,高彦荣,蔡琦,秦尤文,万理萍,蔡宇.骨髓增生异常综合征患者Th1/Th2细胞平衡改变的临床意义[J].中国临床医学,2005,12(4):705-708. 被引量:3

二级参考文献52

  • 1Kimura A, Kishimoto T. IL-6: Regulator of Treg/Th17 balance [J]. Eur J Immunol, 2010, 40(7) : 1830-1835.
  • 2Zhou L, Lopes JE, Chong MM, et al. TGF-beta-induced Foxp3 inhibits T(H) 17 cell differentiation by antagonizing ROR gamma T function [J]. Nature, 2008, 453(7192): 236-240.
  • 3BetteUi E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells [J]. Nature, 2006, 441(7090) : 235-238.
  • 4Bettelli E, Korn T, Kuchroo VK. Th17: The third member of the effector T cell trilogy [ J ]. Curr Opin Immunol, 2007, 19 ( 6 ) : 652-657.
  • 5Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer [ J]. J Clin Invest, 2007, 117 (5) : 1175-1183.
  • 6Kryczek I, Wei S, Zou L, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment [J]. J Immunol, 2007, 178(11) : 6730-6733.
  • 7Voo KS, Wang YH, Santori FR, et al. Identification of IL-17-producing Foxp3^+ regulatory T cells in humans [J]. Proc Natl Acad Sci U S A, 2009, 106(12) : 4793-4798.
  • 8Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J]. Nat Med, 2004, 10(9) : 942-949.
  • 9Ma J, Yu J, Tao X, Cai L, et al. The imbalance between regulatory and IL-17-secreting CD4^+ T cells in lupus patients [ J]. Clin Rheumatol, 2010, 29 ( 11 ) : 1251-1258.
  • 10Eastaff-Leung N, Mabarrack N, Barbour A, et al. Foxp3^+ regulatory T cells, Thl7 effector cells, and cytokine environment in inflammatory bowel disease [ J]. J Clin Immunol, 2010, 30( 1 ): 80-89.

共引文献54

同被引文献134

引证文献14

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部